Annexon [ANNX] vs Third Harmonic Bio [THRD] Detailed Stock Comparison
Annexon
NASDAQ
Loading...
Third Harmonic Bio
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 15 vital metrics comparison: Annexon wins in 5 metrics, Third Harmonic Bio wins in 7 metrics, with 2 ties. Third Harmonic Bio appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Annexon | Third Harmonic Bio | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -2.40 | 12.46 | Annexon |
| Price-to-Book Ratio | 1.41 | 0.89 | Third Harmonic Bio |
| Debt-to-Equity Ratio | 13.88 | 1.10 | Third Harmonic Bio |
| PEG Ratio | -0.05 | 0.17 | Annexon |
| EV/EBITDA | -0.26 | 0.40 | Annexon |
| Profit Margin (TTM) | 0.00% | 0.00% | Tie |
| Operating Margin (TTM) | 0.00% | 0.00% | Tie |
| Return on Equity | -66.75% | -19.94% | Third Harmonic Bio |
| Return on Assets (TTM) | -37.47% | -14.60% | Third Harmonic Bio |
| Free Cash Flow (TTM) | $-118.02M | $-34.51M | Third Harmonic Bio |
| 1-Year Return | -66.25% | -53.82% | Third Harmonic Bio |
| Enterprise Value | $52.25M | $-25.82M | Annexon |
| Revenue per Share (TTM) | $0 | N/A | N/A |
| Earnings per Share (Diluted) | $-1.29 | $-1.24 | Third Harmonic Bio |
| Beta (Stock Volatility) | 1.16 | 2.13 | Annexon |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Annexon vs Third Harmonic Bio Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Annexon | -5.10% | 11.52% | -0.82% | -10.70% | -9.02% | -56.00% |
| Third Harmonic Bio | 0.00% | 0.00% | -1.28% | 4.47% | 56.85% | -51.27% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Annexon | -66.25% | -61.79% | -89.20% | -86.32% | -86.32% | -86.32% |
| Third Harmonic Bio | -53.82% | -70.11% | -70.11% | -70.11% | -70.11% | -70.11% |
News Based Sentiment: Annexon vs Third Harmonic Bio
Annexon
News based Sentiment: NEUTRAL
The month's events center around investor relations and upcoming financial results. While the company is actively engaging with investors, the current financial forecasts suggest a challenging near-term outlook, resulting in a neutral overall sentiment.
Third Harmonic Bio
News sentiment data is not available for Third Harmonic Bio at this time.
Performance & Financial Health Analysis: Annexon vs Third Harmonic Bio
| Metric | ANNX | THRD |
|---|---|---|
| Market Information | ||
| Market Cap | $265.93M | $242.79M |
| Market Cap Category | Small cap | Micro cap |
| 10 Day Avg. Volume | 1,719,515 | 173,590 |
| 90 Day Avg. Volume | 1,370,285 | 175,425 |
| Last Close | $2.42 | $5.38 |
| 52 Week Range | $1.28 - $7.85 | $3.18 - $16.02 |
| % from 52W High | -69.17% | -66.42% |
| All-Time High | $38.01 (Feb 22, 2021) | $24.59 (Oct 31, 2022) |
| % from All-Time High | -93.63% | -78.12% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.00% |
| Operating Margin (TTM) | 0.00% | 0.00% |
| Return on Equity (TTM) | -0.67% | -0.20% |
| Debt to Equity (MRQ) | 13.88 | 1.10 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.81 | $6.06 |
| Cash per Share (MRQ) | $2.07 | $6.02 |
| Operating Cash Flow (TTM) | $-156,156,000 | $-41,687,000 |
| Levered Free Cash Flow (TTM) | $-79,705,504 | $-28,660,250 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Annexon vs Third Harmonic Bio
| Metric | ANNX | THRD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -2.40 | 12.46 |
| Forward P/E | -2.24 | -3.49 |
| PEG Ratio | -0.05 | 0.17 |
| Price to Sales (TTM) | N/A | N/A |
| Price to Book (MRQ) | 1.41 | 0.89 |
| Market Capitalization | ||
| Market Capitalization | $265.93M | $242.79M |
| Enterprise Value | $52.25M | $-25,821,452 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | N/A | N/A |
| Enterprise to EBITDA | -0.26 | 0.40 |
| Risk & Other Metrics | ||
| Beta | 1.16 | 2.13 |
| Book Value per Share (MRQ) | $1.81 | $6.06 |
Financial Statements Comparison: Annexon vs Third Harmonic Bio
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ANNX | THRD |
|---|---|---|
| Revenue/Sales | $0 | $0 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | $44.16M | $10.65M |
| Operating Income (EBIT) | $-51.73M | $-18.72M |
| EBITDA | $-51.11M | $-18.70M |
| Pre-Tax Income | $-49.16M | $-15.83M |
| Income Tax | N/A | N/A |
| Net Income (Profit) | $-49.16M | $-15.83M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ANNX | THRD |
|---|---|---|
| Cash & Equivalents | $97.12M | $271.61M |
| Total Current Assets | $268.16M | $276.00M |
| Total Current Liabilities | $33.55M | $5.10M |
| Long-Term Debt | $25.69M | $2.11M |
| Total Shareholders Equity | $243.79M | $272.62M |
| Retained Earnings | $-765.06M | $-175.52M |
| Property, Plant & Equipment | $18.22M | $2.85M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ANNX | THRD |
|---|---|---|
| Operating Cash Flow | $-51.11M | $-11.78M |
| Capital Expenditures | $-74,000 | $0 |
| Free Cash Flow | $-50.13M | $-13.48M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ANNX | THRD |
|---|---|---|
| Shares Short | 10.14M | 1.42M |
| Short Ratio | 8.69 | 6.95 |
| Short % of Float | 0.12% | 0.05% |
| Average Daily Volume (10 Day) | 1,719,515 | 173,590 |
| Average Daily Volume (90 Day) | 1,370,285 | 175,425 |
| Shares Outstanding | 109.38M | 44.86M |
| Float Shares | 89.06M | 15.60M |
| % Held by Insiders | 0.00% | 0.09% |
| % Held by Institutions | 1.00% | 0.80% |
Dividend Analysis & Yield Comparison: Annexon vs Third Harmonic Bio
| Metric | ANNX | THRD |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |